Daily Roundup

MXO.ASX BRI.ASX HMC.ASX SHV.ASX NEU.ASX

Motio Ltd is riding high as it approaches the end of FY26, delivering a trading update that shows the advertising tech company has maintained impressive momentum despite a challenging environment. May marked the highest revenue month in the company's history, with June on track to smash that record. The company expects Cash EBITDA growth of over 24% for the full year, driven by broad-based strength across its national advertising business and a healthy pipeline of campaigns booked at short notice. With gross margins exceeding 80%, Motio is translating that revenue surge into improved earnings and cash generation. The CEO will provide a detailed breakdown on July 3, and the company enters FY27 with considerable confidence in its forward revenue position.

Big River Industries is charting a more measured course, expecting FY26 EBITDA growth of 8% despite macroeconomic and geopolitical headwinds. The building products company has managed to maintain disciplined margins and control costs, though regional performance remains uneven—Western Australia is firing on all cylinders while Victoria and New Zealand remain soft. The real excitement lies ahead, with the company guiding for double-digit EBITDA growth in FY27, supported by its JBS joint venture and strategic investments in cladding, decorative panels, and plywood. To capitalize on these opportunities, Big River has engaged Greenstone Partners to review strategic options that could enhance shareholder value.

HMC Capital is expanding its reach in the private credit space, securing $1.35 billion in new institutional mandates from global investors seeking exposure to Australian commercial real estate lending. With $375 million already deployed at financial close, the platform now has $1 billion of dry powder lined up for FY27. Once fully deployed, HMC's private credit AUM is expected to climb to approximately $3.3 billion, positioning the company to originate significantly larger loan opportunities and grow its market share while generating recurring funds management earnings.

On the leadership front, Select Harvests has appointed Kristina Hermanson as its new Managing Director and CEO, effective August 3, 2026. Hermanson brings over 25 years of global agribusiness experience, most recently from Nuveen Natural Capital where she managed a $3 billion portfolio. Her previous roles at FMC Corporation, Coca-Cola Amatil, and Archer Daniels Midland give her deep expertise in the sector, and the Board is confident she'll drive growth and value creation for shareholders.

Finally, Neuren Pharmaceuticals received encouraging news from Europe, with the European Medicines Agency's Committee for Medicinal Products for Human Use issuing a positive opinion recommending approval for DAYBU® (trofinetide) to treat neurobehavioral symptoms of Rett syndrome. If greenlit by the European Commission, DAYBU® would be the first treatment for this indication in the EU. Neuren stands to receive $35 million following the first commercial sale, plus additional milestone payments and royalties tied to future sales—a meaningful validation of the company's pipeline and potential revenue stream.